Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation

Cited by (126)

Items 101–126 of 126

1. Components of the endocannabinoid and dopamine systems are dysregulated in Huntington's disease: analysis of publicly available microarray datasets
   Robert B. Laprairie, Amina M. Bagher, Sophie V. Precious, Eileen M. Denovan‐Wright · 2015 · Pharmacology Research & Perspectives
2. Boosting 2-arachidonoylglycerol, but not N-acylethanolamine, ameliorates autism symptoms in VPA-exposed rats by modulating abnormal neuroinflammation
   Feng Wang, Ya Gao, Zehui Liu, Zeyu Cheng, Shidan Liu, Yuting Zhang, Wen Jiang, Mengyuan Zhang, Xiaolei Yang, Mingyang Zou et al. · 2025 · Neuropharmacology
3. The Endogenous Cannabinoid System: A Cadre of Potential Therapeutic Targets
   Steven G. Kinsey, Aron H. Lichtman · 2018 · Springer eBooks
4. Pharmacological Aspects of Anandamide and 2-Arachidonoyglycerol as Bioactive Lipids
   Mireille Alhouayek, Giulio G. Muccioli · 2017 · Elsevier eBooks
5. Quantification of Endocannabinoids from Biological Samples Using Liquid Chromatography–Tandem Mass Spectrometry
   Zhiying Wang, Chenglin Mo, Lynda Faye Bonewald, Marco A. P. Brotto · 2023 · Methods in molecular biology
6. Cell-type specific induction of cyclo-oxygenase-2 in layer II/III prefrontal cortical neurons mediates stress-induced anxiety phenotypes in mice
   Robert J. Fenster, Kenneth M. McCullough, Sergey Naumenko, Andrew Thompson, Claudia Klengel, Allison Rodgers, Joy Otten, Dan Shu, Niki Harris, Torsten Klengel et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
7. Endocannabinoid signaling and stress resilience
   Matthew N. Hill, Sachin Patel · 2019 · Elsevier eBooks
8. New insights into the crosstalk between endocannabinoids and sphingosine-1-phosphate
   Cinzia Rapino, Sara Standoli, Francesca Cencetti, Paola Bruni, Sergio Oddi, Mauro Maccarrone · 2025 · Journal of Biological Chemistry
9. The ever-expanding world of the endocannabinoids: A concise introduction
   Fabiana Piscitelli, Vincenzo Di Marzo · 2015 · Elsevier eBooks
10. Potential Therapeutic Targets of the Endocannabinoid System in Common Neurodegenerative Disorders and Organic Acidemias
    Gabriela Aguilera, Abel Santamarı́a · 2017 · Journal of Inborn Errors of Metabolism and Screening
11. Disaggregating between- and within-person relations for depression and burnout symptoms with cumulative hair cortisol and endocannabinoid concentrations: A multilevel analysis of four annual assessment waves
    Andreas Walther, Clemens Kirschbaum, Susanne Wehrli, Nicole Rothe, Magdalena Wekenborg, Marlene Sophie Penz, Wei Gao · 2021
12. 2-Arachodonoylglycerol-mediated endocannabinoid signaling modulates mechanical hypersensitivity associated with alcohol withdrawal in mice
    Amanda Morgan, Danielle N. Adank, Keenan Johnson, Emily Blunt, Sachin Patel · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
13. Oxidative Metabolites of Endocannabinoids Formed by Cyclooxygenase-2
    Lawrence J. Marnett, Philip J. Kingsley, Daniel J. Hermanson · 2014 · Elsevier eBooks
14. Selectively targeting COX2 decreases anxiety
    Charlotte Harrison · 2013 · Nature Reviews Drug Discovery
15. The endocannabinoid system : a translational study from Achilles tendinosis to cyclooxygenase
    Emmelie Björklund · 2014 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
16. Take an NSAID for Anxiety
    Steven L. Dubovsky · 2013 · Journal watch
17. Endocannabinoid augmentation through substrate-selective COX-2 inhibition: Behavioral and synaptic effects in an animal model of stress-induced anxiety
    Joyonna Gamble‐George · 2016
18. Personal Experiences of the Ocular Sequelæ of Malaria.
    Wm Hislop Manson · 1920 · Europe PMC (PubMed Central)
19. The Endocannabinoids
    STEVEN P. JAMES · 2020 · Cambridge University Press eBooks
20. WWL70 targets the link between 2-arachidonoylglycerol and prostanoid pathways
    Mikiei Tanaka, Yumin Zhang · 2023 · Elsevier eBooks
21. Immune-mediated impairment of tonic immobility defensive behavior in an experimental model of colonic inflammation
    Leda Menescal-de-Oliveira, Mariulza Rocha Brentegani, Fernanda Pincelli Teixeira, Humberto Giusti, Rafael Simone Saia · 2024 · Pflügers Archiv - European Journal of Physiology
22. Additional file 1 of Assessment of NSAIDs as potential inhibitors of the fatty acid amide hydrolase I (FAAH-1) using three different primary fatty acid amide substrates in vitro
    Dongdem, Julius T., Gideon Kofi Helegbe, Opare-Asamoah, Kwame, Cletus Adiyaga Wezena, Augustine Ocloo · 2022 · Figshare
23. Applications of proteochemometrics (PCM) : from species extrapolation to cell-line sensitivity modelling
    Isidro Cortés‐Ciriano · 2015
24. Effect of environmental temperature on oxidative status, inflammatory response and endocannabinoid system at oestrus in dairy cows
    Alice Carbonari, Lorenza Frattina, Matteo Burgio, Vincenzo Cicirelli, Michal Andrzej Kosior, Alessandra Sfacteria, Bianca Gasparrini, Gabriele Marino, Roberta Verde, Fabiana Piscitelli et al. · 2026 · Veterinary Record Open
25. Substrate‐Selective Inhibition of the SARS‐CoV‐2 Papain‐Like Protease: Inhibition of Hydrolysis of Human Over Viral Substrates
    Sakshi Sharma, Peter A. C. Wing, Wojtek Treyde, Shyam Basak, Simeon D. Draganov, Taylah Andrews-Clark, E. Salah, Petra Lukacik, Claire M. Strain-Damerell, Adán Pinto-Fernández et al. · 2026 · Chemistry - A European Journal
26. Nimesulid: Pharmacological and Clinical Profile
    V. V. Afanasyev, Е. Л. Пугачева, Dmitry Anatolyevich Iskra · 2026 · Ambulatornaya khirurgiya = Ambulatory Surgery (Russia)